Celik I - Search Results

1

Plasma fibronectin- and thrombospondin-adhesive molecules during acute attacks and attack-free periods of familial Mediterranean fever.

Ertenli I, Kiraz S, Oztürk MA, Haznedaroglu IC, Celik I, Kirazli S, Calgüneri M. Ertenli I, et al. Among authors: celik i. Rheumatol Int. 2001 Aug;20(6):217-20. doi: 10.1007/s002960100107. Rheumatol Int. 2001. PMID: 11563578

2

Coagulation, fibrinolysis and fibrinolysis inhibitors in haemodialysis patients: contribution of arteriovenous fistula.

Erdem Y, Haznedaroglu IC, Celik I, Yalcin AU, Yasavul U, Turgan C, Caglar S. Erdem Y, et al. Among authors: celik i. Nephrol Dial Transplant. 1996 Jul;11(7):1299-305. Nephrol Dial Transplant. 1996. PMID: 8672026

3

Haemostatic markers of procoagulant imbalance in Behçet's disease.

Haznedaroğlu IC, Ozcebe O, Celik I, Dündar SV, Kirazhi S. Haznedaroğlu IC, et al. Among authors: celik i. Eur J Haematol. 1996 Jul;57(1):107-8. doi: 10.1111/j.1600-0609.1996.tb00499.x. Eur J Haematol. 1996. PMID: 8698121 No abstract available.

4

Local fibrinolysis in native arteriovenous fistulas of haemodialysis patients.

Haznedaroğlu IC, Erdem Y, Celik I, Sayinalp NM, Dündar SV, Cağlar S, Kirazli S. Haznedaroğlu IC, et al. Among authors: celik i. Blood Purif. 1996;14(3):227-33. doi: 10.1159/000170265. Blood Purif. 1996. PMID: 8738536

5

Cytokines affecting megakaryocytopoiesis in rheumatoid arthritis with thrombocytosis.

Ertenli I, Haznedaroğlu IC, Kiraz S, Celik I, Calgüneri M, Kirazhi S. Ertenli I, et al. Among authors: celik i. Rheumatol Int. 1996;16(1):5-8. doi: 10.1007/BF01419947. Rheumatol Int. 1996. PMID: 8783415

6

Agranulocytosis, plasmacytosis, and thrombocytosis followed by a leukemoid reaction due to acute acetaminophen toxicity.

Gürsoy M, Haznedaroğlu IC, Celik I, Sayinalp N, Ozcebe OI, Dündar SV. Gürsoy M, et al. Among authors: celik i. Ann Pharmacother. 1996 Jul-Aug;30(7-8):762-5. doi: 10.1177/106002809603000710. Ann Pharmacother. 1996. PMID: 8826556

7

Effect of prophylactic benzathine penicillin on mucocutaneous symptoms of Behçet's disease.

Calgüneri M, Ertenli I, Kiraz S, Erman M, Celik I. Calgüneri M, et al. Among authors: celik i. Dermatology. 1996;192(2):125-8. doi: 10.1159/000246336. Dermatology. 1996. PMID: 8829493 Clinical Trial.

8

Ifosfamide, mesna and epirubicin as second-line chemotherapy in advanced breast cancer.

Kiraz S, Baltali E, Güler N, Barista I, Benekli M, Celik I, Güllü IH, Kars A, Tekuzman G, Firat D. Kiraz S, et al. Among authors: celik i. J Chemother. 1996 Aug;8(4):310-4. doi: 10.1179/joc.1996.8.4.310. J Chemother. 1996. PMID: 8873839 Clinical Trial.

9

Behçet disease: advantageous against development of neoplasia?

Celík I, Barişta I, Tekuzman G, Kansu E, Kíraz S, Calgünerí M. Celík I, et al. Ann Rheum Dis. 1996 Sep;55(9):648. doi: 10.1136/ard.55.9.648-a. Ann Rheum Dis. 1996. PMID: 8882138 Free PMC article. No abstract available.

10

Impaired haemostatic kinetics and endothelial function in Behçet's disease.

Haznedaroglu IC, Ozcebe OI, Ozdemir O, Celik I, Dündar SV, Kirazli S. Haznedaroglu IC, et al. Among authors: celik i. J Intern Med. 1996 Oct;240(4):181-7. doi: 10.1046/j.1365-2796.1996.396853000.x. J Intern Med. 1996. PMID: 8918508

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

717 results

Search Page

Filters